Nandrolone phenpropionate

苯丙酸诺龙

Report date: 2023/04/25 14:01:45
NME

Base Information

Drug NameNandrolone phenpropionate
Drug Alias NameNandrolone19-去甲睾酮Nandrolonum南诺龙癸酸诺龙 +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsAndrogen deficiencyCritical IllnessMalnutrition +[11] 
Global Approved IndicationsAndrogen deficiencyAnemiaAngioedemas, Hereditary +[4] 
Approved Indications in ChinaBreast Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1959/10/30
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesHuazhong Pharmaceutical Co Ltd
Inactive CompaniesLawson Health Research InstituteOrganon Usa IncNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsBreast Neoplasms
Inactive IndicationsAndrogen deficiencyCritical IllnessMalnutrition +[10] 

Other Information

ATC CodeA14AB01S01XA11
Related LinksWikipediaDrugBankKEGG